FDA approves 30mg dose of generic Opana ER from Impax

07/22/2010 | American City Business Journals

Impax Laboratories received FDA approval for a 30-milligram dose of generic Opana ER (an extended-release pain tablet by Endo Pharmaceuticals Holdings and Penwest Pharmaceuticals). The approval entitles Impax to 180 days of market exclusivity.

View Full Article in:

American City Business Journals